BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 11790801)

  • 1. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.
    Lee EK; Jeon WK; Chae MY; Hong HY; Lee YS; Kim JH; Kwon JY; Kim BC; Park SH
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1021-7. PubMed ID: 19968960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway.
    Janda E; Litos G; Grünert S; Downward J; Beug H
    Oncogene; 2002 Aug; 21(33):5148-59. PubMed ID: 12140765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.
    Janda E; Nevolo M; Lehmann K; Downward J; Beug H; Grieco M
    Oncogene; 2006 Nov; 25(54):7117-30. PubMed ID: 16751808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine PDGFR signaling promotes mammary cancer metastasis.
    Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
    J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
    Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
    Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.
    Maschler S; Grunert S; Danielopol A; Beug H; Wirl G
    Oncogene; 2004 Apr; 23(20):3622-33. PubMed ID: 15116096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition.
    Andarawewa KL; Erickson AC; Chou WS; Costes SV; Gascard P; Mott JD; Bissell MJ; Barcellos-Hoff MH
    Cancer Res; 2007 Sep; 67(18):8662-70. PubMed ID: 17875706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
    Zhang A; Wang MH; Dong Z; Yang T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1323-31. PubMed ID: 16868306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.
    Fischer AN; Herrera B; Mikula M; Proell V; Fuchs E; Gotzmann J; Schulte-Hermann R; Beug H; Mikulits W
    Carcinogenesis; 2005 May; 26(5):931-42. PubMed ID: 15705598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.